Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bansisons Tea Industries, now renamed Novyra Pharmachem Limited, has called its 39th AGM on June 25, 2026 via video conferencing. Ordinary business includes adoption of FY26 (ending March 31, 2026) audited financial statements and re-appointment of Mr. Sandeep Agarwal as director (retiring by rotation). The key special business item is a major capital reduction scheme that proposes cancelling 85.71% of the company's equity shares — reducing the paid-up share count from 63,30,000 to 9,04,286 shares, bringing capital down from Rs. 6.33 crore to Rs. 90.42 lakh. Alongside this, the company plans to write off Rs. 5.42 crore of accumulated losses (out of total Rs. 5.71 crore). Additionally, Mr. Anilkumar Amreliya will be regularized as Executive Director and appointed as Managing Director for 5 years at a monthly salary of Rs. 11,000.
The proposed 85.71% capital reduction will substantially shrink existing shareholders' holdings to roughly 14% of their current size, though the company states no additional cash will be called from shareholders. The loss write-off and capital cleanup aim to present a leaner balance sheet, but investors should evaluate the impact on per-share value and their proportional ownership before the June 18, 2026 cut-off date for e-voting.